Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015414
Filing Date
2018-11-08
Accepted
2018-11-08 07:46:26
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1181930
2 ex31-1.htm EX-31.1 18510
3 ex31-2.htm EX-31.2 18205
4 ex32-1.htm EX-32.1 7743
5 ex32-2.htm EX-32.2 7601
  Complete submission text file 0001493152-18-015414.txt   3786493

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pbi-20180930.xml EX-101.INS 488141
7 XBRL SCHEMA FILE pbi-20180930.xsd EX-101.SCH 40633
8 XBRL CALCULATION FILE pbi-20180930_cal.xml EX-101.CAL 39403
9 XBRL DEFINITION FILE pbi-20180930_def.xml EX-101.DEF 178237
10 XBRL LABEL FILE pbi-20180930_lab.xml EX-101.LAB 262553
11 XBRL PRESENTATION FILE pbi-20180930_pre.xml EX-101.PRE 243415
Mailing Address P.O. BOX 666 OLDWICK NJ 08858
Business Address P.O. BOX 666 OLDWICK NJ 08858 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 181168197
SIC: 2834 Pharmaceutical Preparations